{"id":"7229f667-acb1-4bee-a44e-e65653aeb565","name":"Movano Health","slug":"movano-health","description":"Women's-health smart-ring company (NASDAQ: MOVE; CEO John Mastrototaro) of the consumer Evie Ring (general-wellness) + FDA-cleared B2B EvieMED Ring; financially distressed (going-concern; possible sale).","status":"renamed Corvex, Inc. (NASDAQ: MOVE) after all-stock reverse merger closed Mar 19 2026; pivoted to AI infrastructure; legacy Movano wearables (Evie Ring) sales paused, healthcare assets divestiture-pending","founded":2018,"hq":"Pleasanton, California, USA","fundingTotal":"24000000","type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.prnewswire.com/news-releases/movano-health-receives-fda-clearance-for-eviemed-ring-302319677.html","title":"Movano EvieMED Ring FDA 510(k) clearance (pulse oximeter + HR; Dec 2 2024) - the B2B/clinical variant","sourceName":"Movano (PR Newswire)"},{"url":"https://www.mobihealthnews.com/news/movano-health-secures-fda-clearance-eviemed-ring","title":"Movano EvieMED FDA clearance; consumer Evie = women's-health metrics (cycle/sleep/mood/HR/SpO2)","sourceName":"MobiHealthNews"},{"url":"https://www.sec.gov/Archives/edgar/data/0001734750/000121390025110877/ea0261389-10q_movano.htm","title":"Movano 10-Q (FY2025): going-concern; accumulated deficit $160.5M; runway not beyond Q1 2026; strategic review","sourceName":"SEC EDGAR"},{"url":"https://www.corvex.ai/blog/press-release-corvex-to-go-public-in-all-stock-merger-withmovano-creating-a-pure-play-platform-for-secure-ai-infrastructure-and-high-performanceinference","title":"Corvex to go public in all-stock merger with Movano (pivot to secure AI infrastructure)","sourceName":"Corvex (IR)"},{"url":"https://www.arlnow.com/2026/03/25/va-square-based-ai-company-goes-public-after-merger-with-health-tech-firm/","title":"Va. Square AI company (Corvex) goes public after merger with Movano (closed Mar 19 2026; renamed Mar 23)","sourceName":"ARLnow"}],"keyFacts":[{"label":"Product","value":"Evie Ring (consumer women's-health, general-wellness) + EvieMED Ring (B2B, FDA 510(k) SpO2 cleared Dec 2024)."},{"label":"Risk","value":"Going-concern (deficit $160.5M; runway not beyond Q1 2026; possible sale). RE-VERIFY."},{"label":"Stock ticker","value":"NASDAQ: MOVE"},{"label":"CEO","value":"John Mastrototaro"},{"label":"Company type","value":"Women's-health smart-ring company"}],"aliases":["Movano Inc","Evie Ring","EvieMED Ring"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-03T22:46:34.562Z","updatedAt":"2026-07-08T06:44:58.783Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/movano-health","url":"https://registry.deploy.report/companies/movano-health","name":"Movano Health","alternateName":["Movano Inc","Evie Ring","EvieMED Ring"],"description":"Women's-health smart-ring company (NASDAQ: MOVE; CEO John Mastrototaro) of the consumer Evie Ring (general-wellness) + FDA-cleared B2B EvieMED Ring; financially distressed (going-concern; possible sale).","identifier":"7229f667-acb1-4bee-a44e-e65653aeb565","foundingDate":"2018","address":"Pleasanton, California, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":5,"primary_source_types":["primary-company-ir","primary-sec-filing"]}}}